On June 2, a startup called NewLimit, founded by the crypto billionaire Brian Armstrong, said it had raised a further $435 million, from investors including Peter Thiels Founders Fund, to support what it calls age reprogramming. The company says it is working toward delivering genetic reprogramming instructions to the liver, to treat diseases of that organ
Regulation of the g1/s transition in hepatocytes: involvement of the cyclin-dependent kinase cdk1 in the DNA replication
Schisandrin A protected intestinal epithelial cells from cytotoxicity induced by mycophenolic acid and oxidative damage caused by increasing ROS expression, playing its antioxidant activity (53)
Food you cannot live without
By studying stem cells in mice, scientists at New York Universitys Langone Medical Center found that a signaling pathway called Edn/EdnrB interacts with other pathways, particularly the Mnt signaling pathway